Significant correlation between 14C-5-HT uptake by and 3H-paroxetine binding to platelets from healthy volunteers

      This paper is only available as a PDF. To read, Please Download here.


      The lack of correlation between 5-HT uptake by platelets and the ability of platelet membrane to bind antidepressant drugs, particularly imipramine, has been reported. However, more recently it has been suggested that 3H-paroxetine could be a better drug with which to study the platelet 5-HT uptake mechanism in disease states. We have therefore compared the ability of platelet-rich plasma (PRP) from normal individuals to take up 5-HT with the ability of platelet membranes to bind paroxetine.
      A significant correlation was apparent between the Vmax of 14C-5-HT uptake by PRP and the Bmax of 3H-paroxetine binding to platelet membrane from 30 individuals (r = 0.6468, p = 0.0001). Furthermore, this correlation was highly significant in the 20 female (r = 0.7768, p = 0.00006) but not in the 10 male volunteers. There was also a significant association between Vmax and Bmax and the month of blood sampling but this did not totally account for the correlation between Vmax and Bmax.
      The simultaneous measurement of 5-HT uptake by PRP and paroxetine binding to platelet membranes from both depressed patients and matched controls should be carried out to confirm and extend these findings.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Carroll B.J.
        • Feinberg M.
        • Smouse P.E.
        • Rawson S.G.
        • Greden J.F.
        The Carroll rating scale for depression. Development, reliability and validation.
        Br J Psychiatry. 1981; 138: 194-200
        • Chicz-DeMet A.
        • Reist C.
        • DeMet E.M.
        Relationship between seasonal patterns of platelet serotonin uptake and 3H-imipramine binding in depressed patients and normal controls.
        Prog Neuro-Psychopharmacol & Biol Psychiat. 1991; 15: 25-39
        • D'Haenen H.
        • De Waele M.
        • Leysen J.E.
        Platelet 3H-paroxetine binding in depressed patients.
        Psychiatry Res. 1988; 26: 11-17
        • Faludi G.
        • Magyar I.
        • Tekes K.
        • Tothfalusi L.
        • Magyar K.
        Measurement of 3H-serotonin uptake in blood platelets in major depressive episodes.
        Biol Psychiatry. 1988; 23: 829-833
        • Grahame-Smith D.
        Serotonin function in affective disorders.
        Acta Psychiatr Scand. 1989; 80: 7-12
        • Halbreich U.
        • Rojansky N.
        • Zander K.J.
        • Barkai A.
        Influence of age, sex and diurnal variability on imipramine receptor binding and serotonin uptake in platelets of normal subjects.
        J Psychiatry Res. 1991; 25: 7-18
        • Hrdina P.D.
        Differences between sodium-dependent and desipramine defined 3H-imipramine binding in intact human platelets.
        Biol Psychiatry. 1989; 25: 576-584
        • Klompenhouwer J.L.
        • Fekkes D.
        • van Hulst A.M.
        • Moleman P.
        • Pepplinkhuizen L.
        • Mulder P.G.H.
        Seasonal variations in binding of 3H-paroxetine to blood platelets in healthy volunteers: Indications for a gender difference.
        Biol Psychiatry. 1990; 28: 509-517
        • Langer S.Z.
        • Galzin A.M.
        Studies on the serotonin transporter in platelets.
        Experientia. 1988; 44: 127-130
        • Langer S.Z.
        • Zarifian E.
        • Briley M.
        • Raisman R.
        • Sechter D.
        High affinity binding of 3H-imipramine in brain and platelets and its relevance to the biochemistry of affective disorders.
        Life Sci. 1981; 29: 211-220
        • Malmgren R.
        Methodological aspects of studies on the 5-HT uptake mechanism in normal platelets.
        Acta Pharmacol et Toxicol. 1981; 49: 277-284
        • Malmgren R.
        • Aberg-Wistedt A.
        • Martensson B.
        Aberrant seasonal variations of platelet serotonin uptake in endogenous depression.
        Biol Psychiatry. 1989; 25: 393-402
        • Marcusson J.O.
        • Ross S.B.
        Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets.
        Psychopharmacology. 1990; 102: 145-155
        • Mellerup E.T.
        • Plenge P.
        High affinity binding of 3H-imipramine and 3H-paroxetine to rat neuronal membranes.
        Psychopharmacology. 1986; 89: 436-439
        • Mellerup E.T.
        • Plenge P.
        • Engelstoft M.
        High affinity binding of 3H-paroxetine and 3H-imipramine to human platelet membranes.
        Eur J Pharmacol. 1983; 96: 303-309
        • Plenge P.
        • Mellerup E.T.
        Antidepressive drugs can change the affinity of 3H-imipramine and 3H-paroxetine binding to platelet and neuronal membranes.
        Eur J Pharmacol. 1985; 119: 1-8
        • Raisman R.
        • Briley M.S.
        • Bouchami F.
        • Sechter D.
        • Zarifian E.
        • Langer S.Z.
        3H-imipramine binding and serotonin uptake in platelets from untreated patients and control volunteers.
        Psychopharmacology. 1982; 77: 332-335
        • Rausch J.L.
        • Janowsky D.S.
        • Risch S.C.
        • Huey L.Y.
        A kinetic analysis and replication of decreased platelet serotonin uptake in depressed patients.
        Psychiatry Res. 1986; 19: 105-112
        • Segonzac A.
        • Raisman R.
        • Tateishi T.
        • Schoemaker H.
        • Hicks P.E.
        • Langer S.
        Tryptamine, a substrate for the serotonin transporter in human platelets, modifies the dissociation kinetics of 3H-imipramine binding: possible allosteric interaction.
        J Neurochem. 1985; 44: 349-356
        • Segonzac A.
        • Schoemaker H.
        • Langer S.Z.
        Temperature-dependence of drug interaction with the platelet 5-HT transporter: a clue to the imipramine selectivity paradox.
        J Neurochem. 1987; 48: 331-339
        • Stahl S.M.
        • Meltzer H.Y.
        A kinetic and pharmacological analysis of 5-hydroxytryptamine transport by human platelets and platelet storage granules: comparison with central serotonergic neurons.
        J Pharmacol and Experimental Therapeutics. 1978; 205: 118-132
        • Wood P.L.
        • Suranyi-Cadotte B.E.
        • Nair N.P.V.
        • LaFaille F.
        • Schwartz G.
        Lack of association between 3H-imipramine binding sites and uptake of serotonin in control, depressed and schizophrenic patients.
        Neuropharmacol. 1983; 22: 1211-1214